nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—OPRK1—Progesterone—uterine cancer	0.29	0.38	CbGbCtD
Tapentadol—UGT2B7—Epirubicin—uterine cancer	0.188	0.247	CbGbCtD
Tapentadol—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0874	0.115	CbGbCtD
Tapentadol—CYP2C19—Progesterone—uterine cancer	0.0697	0.0914	CbGbCtD
Tapentadol—CYP2C9—Progesterone—uterine cancer	0.0579	0.076	CbGbCtD
Tapentadol—CYP2D6—Progesterone—uterine cancer	0.053	0.0695	CbGbCtD
Tapentadol—CYP2D6—Doxorubicin—uterine cancer	0.0162	0.0212	CbGbCtD
Tapentadol—Fatigue—Progesterone—uterine cancer	0.00063	0.00265	CcSEcCtD
Tapentadol—Constipation—Progesterone—uterine cancer	0.000625	0.00263	CcSEcCtD
Tapentadol—Dysarthria—Epirubicin—uterine cancer	0.000621	0.00261	CcSEcCtD
Tapentadol—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000619	0.0026	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000603	0.00254	CcSEcCtD
Tapentadol—Feeling abnormal—Progesterone—uterine cancer	0.000602	0.00253	CcSEcCtD
Tapentadol—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000599	0.00252	CcSEcCtD
Tapentadol—Coordination abnormal—Epirubicin—uterine cancer	0.000598	0.00252	CcSEcCtD
Tapentadol—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000594	0.0025	CcSEcCtD
Tapentadol—Thinking abnormal—Doxorubicin—uterine cancer	0.000593	0.0025	CcSEcCtD
Tapentadol—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00059	0.00248	CcSEcCtD
Tapentadol—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000589	0.00248	CcSEcCtD
Tapentadol—Infestation NOS—Etoposide—uterine cancer	0.000586	0.00246	CcSEcCtD
Tapentadol—Infestation—Etoposide—uterine cancer	0.000586	0.00246	CcSEcCtD
Tapentadol—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000583	0.00245	CcSEcCtD
Tapentadol—Urticaria—Progesterone—uterine cancer	0.00058	0.00244	CcSEcCtD
Tapentadol—Abnormal dreams—Epirubicin—uterine cancer	0.00058	0.00244	CcSEcCtD
Tapentadol—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000575	0.00242	CcSEcCtD
Tapentadol—Dysarthria—Doxorubicin—uterine cancer	0.000574	0.00242	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000572	0.0024	CcSEcCtD
Tapentadol—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000571	0.0024	CcSEcCtD
Tapentadol—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000566	0.00238	CcSEcCtD
Tapentadol—Coordination abnormal—Doxorubicin—uterine cancer	0.000553	0.00233	CcSEcCtD
Tapentadol—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000546	0.00229	CcSEcCtD
Tapentadol—Hypersensitivity—Progesterone—uterine cancer	0.000538	0.00226	CcSEcCtD
Tapentadol—Abnormal dreams—Doxorubicin—uterine cancer	0.000537	0.00226	CcSEcCtD
Tapentadol—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000526	0.00221	CcSEcCtD
Tapentadol—Asthenia—Progesterone—uterine cancer	0.000524	0.0022	CcSEcCtD
Tapentadol—Hypoaesthesia—Etoposide—uterine cancer	0.000523	0.0022	CcSEcCtD
Tapentadol—Urinary tract disorder—Etoposide—uterine cancer	0.000519	0.00219	CcSEcCtD
Tapentadol—Pruritus—Progesterone—uterine cancer	0.000517	0.00217	CcSEcCtD
Tapentadol—Oedema—Dactinomycin—uterine cancer	0.000516	0.00217	CcSEcCtD
Tapentadol—Urethral disorder—Etoposide—uterine cancer	0.000516	0.00217	CcSEcCtD
Tapentadol—Infection—Dactinomycin—uterine cancer	0.000513	0.00216	CcSEcCtD
Tapentadol—Mental disability—Epirubicin—uterine cancer	0.00051	0.00214	CcSEcCtD
Tapentadol—Diarrhoea—Progesterone—uterine cancer	0.0005	0.0021	CcSEcCtD
Tapentadol—Eye disorder—Etoposide—uterine cancer	0.000492	0.00207	CcSEcCtD
Tapentadol—Cardiac disorder—Etoposide—uterine cancer	0.000488	0.00205	CcSEcCtD
Tapentadol—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000488	0.00205	CcSEcCtD
Tapentadol—Dizziness—Progesterone—uterine cancer	0.000483	0.00203	CcSEcCtD
Tapentadol—Angiopathy—Etoposide—uterine cancer	0.000477	0.00201	CcSEcCtD
Tapentadol—Immune system disorder—Etoposide—uterine cancer	0.000475	0.002	CcSEcCtD
Tapentadol—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000475	0.002	CcSEcCtD
Tapentadol—Mediastinal disorder—Etoposide—uterine cancer	0.000474	0.00199	CcSEcCtD
Tapentadol—Chills—Etoposide—uterine cancer	0.000472	0.00199	CcSEcCtD
Tapentadol—Mental disability—Doxorubicin—uterine cancer	0.000471	0.00198	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00047	0.00198	CcSEcCtD
Tapentadol—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000468	0.00197	CcSEcCtD
Tapentadol—Vomiting—Progesterone—uterine cancer	0.000465	0.00195	CcSEcCtD
Tapentadol—Rash—Progesterone—uterine cancer	0.000461	0.00194	CcSEcCtD
Tapentadol—Dermatitis—Progesterone—uterine cancer	0.00046	0.00194	CcSEcCtD
Tapentadol—Headache—Progesterone—uterine cancer	0.000458	0.00193	CcSEcCtD
Tapentadol—Hot flush—Epirubicin—uterine cancer	0.000456	0.00192	CcSEcCtD
Tapentadol—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000453	0.00191	CcSEcCtD
Tapentadol—Menopausal symptoms—Epirubicin—uterine cancer	0.000452	0.0019	CcSEcCtD
Tapentadol—Decreased appetite—Dactinomycin—uterine cancer	0.000449	0.00189	CcSEcCtD
Tapentadol—Fatigue—Dactinomycin—uterine cancer	0.000445	0.00187	CcSEcCtD
Tapentadol—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000438	0.00184	CcSEcCtD
Tapentadol—Lethargy—Epirubicin—uterine cancer	0.000435	0.00183	CcSEcCtD
Tapentadol—Nausea—Progesterone—uterine cancer	0.000434	0.00183	CcSEcCtD
Tapentadol—Osteoarthritis—Epirubicin—uterine cancer	0.000426	0.00179	CcSEcCtD
Tapentadol—Feeling abnormal—Dactinomycin—uterine cancer	0.000426	0.00179	CcSEcCtD
Tapentadol—Hot flush—Doxorubicin—uterine cancer	0.000422	0.00177	CcSEcCtD
Tapentadol—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000421	0.00177	CcSEcCtD
Tapentadol—Menopausal symptoms—Doxorubicin—uterine cancer	0.000418	0.00176	CcSEcCtD
Tapentadol—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000417	0.00176	CcSEcCtD
Tapentadol—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000417	0.00175	CcSEcCtD
Tapentadol—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000415	0.00174	CcSEcCtD
Tapentadol—Vertigo—Etoposide—uterine cancer	0.000411	0.00173	CcSEcCtD
Tapentadol—Loss of consciousness—Etoposide—uterine cancer	0.000402	0.00169	CcSEcCtD
Tapentadol—Lethargy—Doxorubicin—uterine cancer	0.000402	0.00169	CcSEcCtD
Tapentadol—Ataxia—Epirubicin—uterine cancer	0.000401	0.00169	CcSEcCtD
Tapentadol—Cough—Etoposide—uterine cancer	0.0004	0.00168	CcSEcCtD
Tapentadol—Convulsion—Etoposide—uterine cancer	0.000397	0.00167	CcSEcCtD
Tapentadol—Osteoarthritis—Doxorubicin—uterine cancer	0.000394	0.00166	CcSEcCtD
Tapentadol—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000393	0.00165	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000387	0.00163	CcSEcCtD
Tapentadol—Breast disorder—Epirubicin—uterine cancer	0.000385	0.00162	CcSEcCtD
Tapentadol—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000384	0.00161	CcSEcCtD
Tapentadol—Nasopharyngitis—Epirubicin—uterine cancer	0.000381	0.0016	CcSEcCtD
Tapentadol—Hypersensitivity—Dactinomycin—uterine cancer	0.00038	0.0016	CcSEcCtD
Tapentadol—Confusional state—Etoposide—uterine cancer	0.000377	0.00159	CcSEcCtD
Tapentadol—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000376	0.00158	CcSEcCtD
Tapentadol—Anaphylactic shock—Etoposide—uterine cancer	0.000374	0.00157	CcSEcCtD
Tapentadol—Infection—Etoposide—uterine cancer	0.000371	0.00156	CcSEcCtD
Tapentadol—Ataxia—Doxorubicin—uterine cancer	0.000371	0.00156	CcSEcCtD
Tapentadol—Asthenia—Dactinomycin—uterine cancer	0.00037	0.00156	CcSEcCtD
Tapentadol—Tachycardia—Etoposide—uterine cancer	0.000365	0.00153	CcSEcCtD
Tapentadol—Skin disorder—Etoposide—uterine cancer	0.000363	0.00153	CcSEcCtD
Tapentadol—Hyperhidrosis—Etoposide—uterine cancer	0.000361	0.00152	CcSEcCtD
Tapentadol—Breast disorder—Doxorubicin—uterine cancer	0.000356	0.0015	CcSEcCtD
Tapentadol—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000355	0.00149	CcSEcCtD
Tapentadol—Diarrhoea—Dactinomycin—uterine cancer	0.000353	0.00149	CcSEcCtD
Tapentadol—Nasopharyngitis—Doxorubicin—uterine cancer	0.000353	0.00148	CcSEcCtD
Tapentadol—Hypotension—Etoposide—uterine cancer	0.000349	0.00147	CcSEcCtD
Tapentadol—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000348	0.00146	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000342	0.00144	CcSEcCtD
Tapentadol—Pollakiuria—Epirubicin—uterine cancer	0.00034	0.00143	CcSEcCtD
Tapentadol—Paraesthesia—Etoposide—uterine cancer	0.000336	0.00141	CcSEcCtD
Tapentadol—Weight decreased—Epirubicin—uterine cancer	0.000333	0.0014	CcSEcCtD
Tapentadol—Dyspnoea—Etoposide—uterine cancer	0.000333	0.0014	CcSEcCtD
Tapentadol—Somnolence—Etoposide—uterine cancer	0.000332	0.0014	CcSEcCtD
Tapentadol—Infestation—Epirubicin—uterine cancer	0.000328	0.00138	CcSEcCtD
Tapentadol—Infestation NOS—Epirubicin—uterine cancer	0.000328	0.00138	CcSEcCtD
Tapentadol—Vomiting—Dactinomycin—uterine cancer	0.000328	0.00138	CcSEcCtD
Tapentadol—Rash—Dactinomycin—uterine cancer	0.000326	0.00137	CcSEcCtD
Tapentadol—Decreased appetite—Etoposide—uterine cancer	0.000325	0.00137	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Etoposide—uterine cancer	0.000323	0.00136	CcSEcCtD
Tapentadol—Fatigue—Etoposide—uterine cancer	0.000322	0.00136	CcSEcCtD
Tapentadol—Constipation—Etoposide—uterine cancer	0.00032	0.00134	CcSEcCtD
Tapentadol—Urinary tract infection—Epirubicin—uterine cancer	0.000319	0.00134	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000317	0.00133	CcSEcCtD
Tapentadol—Pollakiuria—Doxorubicin—uterine cancer	0.000315	0.00132	CcSEcCtD
Tapentadol—Weight decreased—Doxorubicin—uterine cancer	0.000308	0.0013	CcSEcCtD
Tapentadol—Feeling abnormal—Etoposide—uterine cancer	0.000308	0.0013	CcSEcCtD
Tapentadol—Nausea—Dactinomycin—uterine cancer	0.000307	0.00129	CcSEcCtD
Tapentadol—Infestation NOS—Doxorubicin—uterine cancer	0.000304	0.00128	CcSEcCtD
Tapentadol—Infestation—Doxorubicin—uterine cancer	0.000304	0.00128	CcSEcCtD
Tapentadol—Bradycardia—Epirubicin—uterine cancer	0.0003	0.00126	CcSEcCtD
Tapentadol—Urticaria—Etoposide—uterine cancer	0.000297	0.00125	CcSEcCtD
Tapentadol—Urinary tract infection—Doxorubicin—uterine cancer	0.000295	0.00124	CcSEcCtD
Tapentadol—Hypoaesthesia—Epirubicin—uterine cancer	0.000293	0.00123	CcSEcCtD
Tapentadol—Urinary tract disorder—Epirubicin—uterine cancer	0.000291	0.00122	CcSEcCtD
Tapentadol—Connective tissue disorder—Epirubicin—uterine cancer	0.00029	0.00122	CcSEcCtD
Tapentadol—Urethral disorder—Epirubicin—uterine cancer	0.000289	0.00122	CcSEcCtD
Tapentadol—Visual impairment—Epirubicin—uterine cancer	0.000284	0.0012	CcSEcCtD
Tapentadol—Bradycardia—Doxorubicin—uterine cancer	0.000278	0.00117	CcSEcCtD
Tapentadol—Eye disorder—Epirubicin—uterine cancer	0.000276	0.00116	CcSEcCtD
Tapentadol—Hypersensitivity—Etoposide—uterine cancer	0.000275	0.00116	CcSEcCtD
Tapentadol—Cardiac disorder—Epirubicin—uterine cancer	0.000274	0.00115	CcSEcCtD
Tapentadol—Hypoaesthesia—Doxorubicin—uterine cancer	0.000271	0.00114	CcSEcCtD
Tapentadol—Urinary tract disorder—Doxorubicin—uterine cancer	0.000269	0.00113	CcSEcCtD
Tapentadol—Asthenia—Etoposide—uterine cancer	0.000268	0.00113	CcSEcCtD
Tapentadol—Connective tissue disorder—Doxorubicin—uterine cancer	0.000268	0.00113	CcSEcCtD
Tapentadol—Angiopathy—Epirubicin—uterine cancer	0.000268	0.00113	CcSEcCtD
Tapentadol—Urethral disorder—Doxorubicin—uterine cancer	0.000267	0.00113	CcSEcCtD
Tapentadol—Immune system disorder—Epirubicin—uterine cancer	0.000266	0.00112	CcSEcCtD
Tapentadol—Mediastinal disorder—Epirubicin—uterine cancer	0.000266	0.00112	CcSEcCtD
Tapentadol—Chills—Epirubicin—uterine cancer	0.000265	0.00111	CcSEcCtD
Tapentadol—Pruritus—Etoposide—uterine cancer	0.000264	0.00111	CcSEcCtD
Tapentadol—Visual impairment—Doxorubicin—uterine cancer	0.000263	0.00111	CcSEcCtD
Tapentadol—Mental disorder—Epirubicin—uterine cancer	0.000258	0.00109	CcSEcCtD
Tapentadol—Malnutrition—Epirubicin—uterine cancer	0.000257	0.00108	CcSEcCtD
Tapentadol—Diarrhoea—Etoposide—uterine cancer	0.000256	0.00108	CcSEcCtD
Tapentadol—Eye disorder—Doxorubicin—uterine cancer	0.000255	0.00107	CcSEcCtD
Tapentadol—Cardiac disorder—Doxorubicin—uterine cancer	0.000253	0.00107	CcSEcCtD
Tapentadol—Tension—Epirubicin—uterine cancer	0.000252	0.00106	CcSEcCtD
Tapentadol—Nervousness—Epirubicin—uterine cancer	0.000249	0.00105	CcSEcCtD
Tapentadol—Angiopathy—Doxorubicin—uterine cancer	0.000248	0.00104	CcSEcCtD
Tapentadol—Dizziness—Etoposide—uterine cancer	0.000247	0.00104	CcSEcCtD
Tapentadol—Immune system disorder—Doxorubicin—uterine cancer	0.000246	0.00104	CcSEcCtD
Tapentadol—Mediastinal disorder—Doxorubicin—uterine cancer	0.000246	0.00103	CcSEcCtD
Tapentadol—Chills—Doxorubicin—uterine cancer	0.000245	0.00103	CcSEcCtD
Tapentadol—Vision blurred—Epirubicin—uterine cancer	0.000242	0.00102	CcSEcCtD
Tapentadol—Mental disorder—Doxorubicin—uterine cancer	0.000239	0.00101	CcSEcCtD
Tapentadol—Vomiting—Etoposide—uterine cancer	0.000238	0.001	CcSEcCtD
Tapentadol—Malnutrition—Doxorubicin—uterine cancer	0.000238	0.000999	CcSEcCtD
Tapentadol—Agitation—Epirubicin—uterine cancer	0.000236	0.000992	CcSEcCtD
Tapentadol—Rash—Etoposide—uterine cancer	0.000236	0.000991	CcSEcCtD
Tapentadol—Dermatitis—Etoposide—uterine cancer	0.000235	0.00099	CcSEcCtD
Tapentadol—Headache—Etoposide—uterine cancer	0.000234	0.000985	CcSEcCtD
Tapentadol—Tension—Doxorubicin—uterine cancer	0.000233	0.00098	CcSEcCtD
Tapentadol—Nervousness—Doxorubicin—uterine cancer	0.000231	0.00097	CcSEcCtD
Tapentadol—Vertigo—Epirubicin—uterine cancer	0.000231	0.00097	CcSEcCtD
Tapentadol—Syncope—Epirubicin—uterine cancer	0.00023	0.000968	CcSEcCtD
Tapentadol—Palpitations—Epirubicin—uterine cancer	0.000227	0.000954	CcSEcCtD
Tapentadol—Loss of consciousness—Epirubicin—uterine cancer	0.000226	0.000949	CcSEcCtD
Tapentadol—Cough—Epirubicin—uterine cancer	0.000224	0.000942	CcSEcCtD
Tapentadol—Vision blurred—Doxorubicin—uterine cancer	0.000224	0.000942	CcSEcCtD
Tapentadol—Convulsion—Epirubicin—uterine cancer	0.000222	0.000936	CcSEcCtD
Tapentadol—Nausea—Etoposide—uterine cancer	0.000222	0.000934	CcSEcCtD
Tapentadol—Arthralgia—Epirubicin—uterine cancer	0.000219	0.000919	CcSEcCtD
Tapentadol—Agitation—Doxorubicin—uterine cancer	0.000218	0.000918	CcSEcCtD
Tapentadol—Anxiety—Epirubicin—uterine cancer	0.000218	0.000916	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000217	0.000913	CcSEcCtD
Tapentadol—Dry mouth—Epirubicin—uterine cancer	0.000214	0.000899	CcSEcCtD
Tapentadol—Vertigo—Doxorubicin—uterine cancer	0.000213	0.000898	CcSEcCtD
Tapentadol—Syncope—Doxorubicin—uterine cancer	0.000213	0.000896	CcSEcCtD
Tapentadol—Confusional state—Epirubicin—uterine cancer	0.000211	0.000889	CcSEcCtD
Tapentadol—Palpitations—Doxorubicin—uterine cancer	0.00021	0.000883	CcSEcCtD
Tapentadol—Anaphylactic shock—Epirubicin—uterine cancer	0.000209	0.000881	CcSEcCtD
Tapentadol—Oedema—Epirubicin—uterine cancer	0.000209	0.000881	CcSEcCtD
Tapentadol—Loss of consciousness—Doxorubicin—uterine cancer	0.000209	0.000878	CcSEcCtD
Tapentadol—Infection—Epirubicin—uterine cancer	0.000208	0.000875	CcSEcCtD
Tapentadol—Cough—Doxorubicin—uterine cancer	0.000207	0.000872	CcSEcCtD
Tapentadol—Shock—Epirubicin—uterine cancer	0.000206	0.000867	CcSEcCtD
Tapentadol—Convulsion—Doxorubicin—uterine cancer	0.000206	0.000866	CcSEcCtD
Tapentadol—Nervous system disorder—Epirubicin—uterine cancer	0.000205	0.000864	CcSEcCtD
Tapentadol—Tachycardia—Epirubicin—uterine cancer	0.000204	0.00086	CcSEcCtD
Tapentadol—Skin disorder—Epirubicin—uterine cancer	0.000203	0.000856	CcSEcCtD
Tapentadol—Hyperhidrosis—Epirubicin—uterine cancer	0.000203	0.000852	CcSEcCtD
Tapentadol—Arthralgia—Doxorubicin—uterine cancer	0.000202	0.000851	CcSEcCtD
Tapentadol—Anxiety—Doxorubicin—uterine cancer	0.000202	0.000848	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000201	0.000845	CcSEcCtD
Tapentadol—Dry mouth—Doxorubicin—uterine cancer	0.000198	0.000832	CcSEcCtD
Tapentadol—Hypotension—Epirubicin—uterine cancer	0.000196	0.000823	CcSEcCtD
Tapentadol—Confusional state—Doxorubicin—uterine cancer	0.000195	0.000822	CcSEcCtD
Tapentadol—Anaphylactic shock—Doxorubicin—uterine cancer	0.000194	0.000815	CcSEcCtD
Tapentadol—Oedema—Doxorubicin—uterine cancer	0.000194	0.000815	CcSEcCtD
Tapentadol—Infection—Doxorubicin—uterine cancer	0.000193	0.00081	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000191	0.000803	CcSEcCtD
Tapentadol—Shock—Doxorubicin—uterine cancer	0.000191	0.000802	CcSEcCtD
Tapentadol—Nervous system disorder—Doxorubicin—uterine cancer	0.00019	0.0008	CcSEcCtD
Tapentadol—Insomnia—Epirubicin—uterine cancer	0.000189	0.000797	CcSEcCtD
Tapentadol—Tachycardia—Doxorubicin—uterine cancer	0.000189	0.000796	CcSEcCtD
Tapentadol—Skin disorder—Doxorubicin—uterine cancer	0.000188	0.000792	CcSEcCtD
Tapentadol—Paraesthesia—Epirubicin—uterine cancer	0.000188	0.000791	CcSEcCtD
Tapentadol—Hyperhidrosis—Doxorubicin—uterine cancer	0.000187	0.000788	CcSEcCtD
Tapentadol—Dyspnoea—Epirubicin—uterine cancer	0.000187	0.000786	CcSEcCtD
Tapentadol—Somnolence—Epirubicin—uterine cancer	0.000186	0.000783	CcSEcCtD
Tapentadol—Dyspepsia—Epirubicin—uterine cancer	0.000184	0.000776	CcSEcCtD
Tapentadol—Decreased appetite—Epirubicin—uterine cancer	0.000182	0.000766	CcSEcCtD
Tapentadol—Hypotension—Doxorubicin—uterine cancer	0.000181	0.000762	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000181	0.000761	CcSEcCtD
Tapentadol—Fatigue—Epirubicin—uterine cancer	0.000181	0.00076	CcSEcCtD
Tapentadol—Constipation—Epirubicin—uterine cancer	0.000179	0.000754	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000177	0.000743	CcSEcCtD
Tapentadol—Insomnia—Doxorubicin—uterine cancer	0.000175	0.000737	CcSEcCtD
Tapentadol—Paraesthesia—Doxorubicin—uterine cancer	0.000174	0.000732	CcSEcCtD
Tapentadol—Dyspnoea—Doxorubicin—uterine cancer	0.000173	0.000727	CcSEcCtD
Tapentadol—Feeling abnormal—Epirubicin—uterine cancer	0.000173	0.000726	CcSEcCtD
Tapentadol—Somnolence—Doxorubicin—uterine cancer	0.000172	0.000725	CcSEcCtD
Tapentadol—Dyspepsia—Doxorubicin—uterine cancer	0.000171	0.000718	CcSEcCtD
Tapentadol—Decreased appetite—Doxorubicin—uterine cancer	0.000169	0.000709	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000167	0.000704	CcSEcCtD
Tapentadol—Fatigue—Doxorubicin—uterine cancer	0.000167	0.000703	CcSEcCtD
Tapentadol—Urticaria—Epirubicin—uterine cancer	0.000166	0.0007	CcSEcCtD
Tapentadol—Constipation—Doxorubicin—uterine cancer	0.000166	0.000697	CcSEcCtD
Tapentadol—Feeling abnormal—Doxorubicin—uterine cancer	0.00016	0.000672	CcSEcCtD
Tapentadol—Hypersensitivity—Epirubicin—uterine cancer	0.000154	0.000649	CcSEcCtD
Tapentadol—Urticaria—Doxorubicin—uterine cancer	0.000154	0.000648	CcSEcCtD
Tapentadol—Asthenia—Epirubicin—uterine cancer	0.00015	0.000632	CcSEcCtD
Tapentadol—Pruritus—Epirubicin—uterine cancer	0.000148	0.000623	CcSEcCtD
Tapentadol—Diarrhoea—Epirubicin—uterine cancer	0.000143	0.000603	CcSEcCtD
Tapentadol—Hypersensitivity—Doxorubicin—uterine cancer	0.000143	0.000601	CcSEcCtD
Tapentadol—Asthenia—Doxorubicin—uterine cancer	0.000139	0.000585	CcSEcCtD
Tapentadol—Dizziness—Epirubicin—uterine cancer	0.000139	0.000583	CcSEcCtD
Tapentadol—Pruritus—Doxorubicin—uterine cancer	0.000137	0.000577	CcSEcCtD
Tapentadol—Vomiting—Epirubicin—uterine cancer	0.000133	0.00056	CcSEcCtD
Tapentadol—Diarrhoea—Doxorubicin—uterine cancer	0.000133	0.000558	CcSEcCtD
Tapentadol—Rash—Epirubicin—uterine cancer	0.000132	0.000556	CcSEcCtD
Tapentadol—Dermatitis—Epirubicin—uterine cancer	0.000132	0.000555	CcSEcCtD
Tapentadol—Headache—Epirubicin—uterine cancer	0.000131	0.000552	CcSEcCtD
Tapentadol—Dizziness—Doxorubicin—uterine cancer	0.000128	0.000539	CcSEcCtD
Tapentadol—Nausea—Epirubicin—uterine cancer	0.000124	0.000523	CcSEcCtD
Tapentadol—Vomiting—Doxorubicin—uterine cancer	0.000123	0.000518	CcSEcCtD
Tapentadol—Rash—Doxorubicin—uterine cancer	0.000122	0.000514	CcSEcCtD
Tapentadol—Dermatitis—Doxorubicin—uterine cancer	0.000122	0.000514	CcSEcCtD
Tapentadol—Headache—Doxorubicin—uterine cancer	0.000121	0.000511	CcSEcCtD
Tapentadol—Nausea—Doxorubicin—uterine cancer	0.000115	0.000484	CcSEcCtD
